Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 10-sep-2026 · last seen 10-sep-2026

LpD3.5 Postbiotic

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-08-31 — LpD3.5 Intervention Study in Older Adults- LISA-I Trial: 2026 — LISA-I trial protocol registered: 60-day randomized placebo-controlled study of heat-inactivated LpD3.5 in adults ≥60 with MCI, measuring gut permeability, inflammation, microbiome composition, and cognition (protocol only, no efficacy readout). [human-rct] (novelty: 3)

Open questions

Related

Contributing findings

clinicaltrials trial early human-rct
LpD3.5 Intervention Study in Older Adults- LISA-I Trial
31-aug-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18